A major Canadian bank has changed its sentiment on cannabis stocks and increased its list of recommended stocks, report says.
Toronto-Dominion (TD) Bank has added 13 cannabis stocks to a list its advisers use as guidance before recommending to investors, a report from The Globe and Mail indicated on Sunday (July 1). This list now includes a total of 16 cannabis listings across the Canadian public markets.
According a spokesperson for TD, in order to qualify for the bank’s list stocks can only be listed on the Toronto Stock Exchange (TSX) or TSX Venture Exchange, removing the Canadian Securities Exchange (CSE) and the Aequitas NEO Exchange.
The report also indicates none of the four leading Canadian marijuana exchange-traded funds (ETFs) made it into the TD list.
US exposure leaves two major cannabis companies off the list
Issuers will also be required to not have any sort of exposure into the US cannabis producing market. Despite several states legalizing the drug and a grassroots movement to legalize it completely, under the federal umbrella cannabis remains illegal.
Due to this restrictions, Aurora Cannabis (TSX:ACB) and Aphria (TSX:APH) were excluded from the TD list despite being two of the biggest market-cap companies in the space. Combined, the two producers amount to nearly a $C8 billion market-cap and trade on the TSX.
In February Aphria dumped its US assets after a standoff with Canadian market regulators over the legality of listing on the TSX and owning an interest in the technically illegal market.
The Canadian producer was forced to sell an Arizona-based cannabis producer and has set out to eliminate its stake in Liberty Health Sciences (CSE:LHS). Aphria sold 26,716,025 shares it owned in Liberty Health, leaving the company with a 28.1 percent interest in the US operator, set to be divested after a lock-up period is completed.
Aphria intended to sell its stake of Copperstate Farms, the Arizona producer to Liberty Health. However, shareholders of Copperstate voted against the purchase and exercised their right of first refusal.
Similarly, in June, Aurora announced it will be divesting its shares and warrants of subsidiary Australis Capital, an investment company seeking assets and interest in the real estate and cannabis sectors in the US.
Canadian regulators offer guidance on US risk
This year, after the Aphria dispute with the TMX Group, the Canadian Securities Administrators (CSA) issued an update on the stance of cannabis companies with association to the US market.
“A disclosure-based approach remains appropriate in the current circumstances,” CSA chair Louis Morisset said after the regulator reviewed the delisting potential and risk scenarios of these stocks.
However, in order to maintain a TSX or TSXV listing, cannabis companies still can’t hold interest below the border. Cannabis stocks in the CSE benefited from the CSA ruling and even enjoyed a newfound bullish sentiment from financial experts.
Despite earlier in the year showing a hesitation to recommend these stocks, TD has turned around and accepted them now in terms of what its advisors can recommend to investors.
“Our most recent update reflects our ongoing evaluation of this emerging market,” TD spokesman Paolo Pasquini told The Globe and Mail. “We expect our views will continue to evolve and develop with the industry.”
Here’s a look at the complete list of recommended cannabis stocks on TD’s list:
- Canopy Growth (TSX:WEED)
- Cronos Group (TSX:CRON)
- CannTrust Holdings (TSX:TRST)
- MedReleaf (TSX:LEAF)
- Neptune Technologies & Bioressources (TSX:NEPT)
- Emblem (TSXV:EMC)
- Emerald Health Therapeutics (TSXV:EMH)
- Naturally Splendid (TSXV:NSP)
- Weed MD (TSXV:WMD)
- Tetra Bio-Pharma (TSXV:TBP)
- The Supreme Cannabis Company (TSXV:FIRE)
- Hydropothecary (TSXV:HEXO)
- Abcann Global (TSXV:ABCN)
- Newstrike Resources (TSXV:HIP)
- ICC Labs (TSXV:ICC)
- Harvest One Cannabis (TSXV:HVT)
- Delta 9 Cannabis (TSXV:NINE)
- CBD Med Research (TSXV:CBM/H)
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: Emblem, Naturally Splendid, Harvest One Cannabis and The Supreme Cannabis Company are clients of the Investing News Network. This article is not paid-for content.
Mergers and acquisitions (M&A) in cannabis space have helped boost the industry to new levels.
Strategic sale of non-core assets by Lobe adds non-dilutive capital and shareholder value
Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce, further to its press release dated February 23, 2021, that it has completed the sale to Ionic Brands Corp. (“Ionic Brands”) of Lobe’s non-core cannabis assets relating to Washington-based Cowlitz County Cannabis Cultivation Inc. (“Cowlitz”) held by Lobe’s subsidiary vendor, Green Star Biosciences Inc. (the “Transaction”).
Seattle Area Grocery Chain Metropolitan Market to Begin Carrying KOIOS and Fit Soda on March 22, 2021
Adding to its existing presence on the west coast of the United States, all five KOIOS™ flavours and all four Fit Soda™ flavours will be carried in Metropolitan Market stores beginning on Monday, March 22, 2021. Serving the Seattle-Tacoma area (population 3.87 million), Metropolitan Market is one of five chains under its parent firm Good Food Holdings, which has a total of 51 stores in California, Oregon, and Washington State.
Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that beginning on Monday, March 22, 2021, Koios’ entire line of canned beverage products will be sold at all locations of Metropolitan Market, an urban format supermarket chain in the Seattle-Tacoma area of Washington State. In Q1 2021, the Company announced multiple placements of its beverage products with regional grocers in markets on the west coast of the United States including Market of Choice in Oregon Jensen’s in Southern California and major natural grocery chain Sprouts Farmers Market which has a substantial west coast presence with over one third of its locations (360+ stores across 23 states) in California as well as Washington State 1 . The Company has also recently announced other developments relating to its expansion efforts being undertaken in 2021 such as an in-house beverage canning facility and distribution agreements with regional and national wholesale partners.
Pineapple Express Delivery Partners with CannTrust to Offer Same-Day and Next-Day Delivery for estoraTM Medical Cannabis Patients in Ontario
Ensuring estoraTMpatients have seamless access to their high-quality medical cannabis products
World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announce that its subsidiary Pineapple Express Delivery Inc. (“Pineapple Express Delivery” or “PED”), a leading logistics technology company offering compliant and secure delivery of controlled substances and regulated products, has partnered with CannTrust Inc. to bring same-day and next-day delivery to estoraTM medical cannabis patients in Ontario
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.